Business Description
Sensus Healthcare Inc
NAICS : 339112
SIC : 3841
ISIN : US81728J1097
Total Employee Number:
60Description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 44.92 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 5.75 | |||||
Beneish M-Score | -3.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.4 | |||||
3-Year Book Growth Rate | -0.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.89 | |||||
9-Day RSI | 60.73 | |||||
14-Day RSI | 56.08 | |||||
3-1 Month Momentum % | -38.3 | |||||
6-1 Month Momentum % | -44.5 | |||||
12-1 Month Momentum % | -35.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.27 | |||||
Quick Ratio | 4.45 | |||||
Cash Ratio | 3.13 | |||||
Days Inventory | 345.7 | |||||
Days Sales Outstanding | 160.68 | |||||
Days Payable | 128.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.29 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.74 | |||||
Operating Margin % | -53.34 | |||||
Net Margin % | -34.5 | |||||
EBITDA Margin % | -50.5 | |||||
FCF Margin % | -3.3 | |||||
OCF Margin % | -2.45 | |||||
ROE % | -15.55 | |||||
ROA % | -13.78 | |||||
ROIC % | -27.11 | |||||
3-Year ROIIC % | -751.65 | |||||
ROC (Joel Greenblatt) % | -48.25 | |||||
ROCE % | -23.9 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 26.29 | |||||
Shiller PE Ratio | 64.77 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.12 | |||||
EV-to-EBIT | -2.76 | |||||
EV-to-EBITDA | -2.91 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-Forward-Revenue | 1.49 | |||||
EV-to-FCF | -44.75 | |||||
Price-to-GF-Value | 1.14 | |||||
Price-to-Projected-FCF | 3.83 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 1.4 | |||||
| Price-to-Net-Cash | 4.12 | |||||
Earnings Yield (Greenblatt) % | -36.23 | |||||
FCF Yield % | -1.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sensus Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 19.361 | ||
| EPS (TTM) (€) | -0.403 | ||
| Beta | -0.1086 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.4 | ||
| Volatility % | 72.05 | ||
| 14-Day RSI | 56.08 | ||
| 14-Day ATR (€) | 0.093397 | ||
| 20-Day SMA (€) | 2.573 | ||
| 12-1 Month Momentum % | -35.91 | ||
| 52-Week Range (€) | 2.26 - 4.82 | ||
| Shares Outstanding (Mil) | 16.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sensus Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sensus Healthcare Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 114 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 16:30 | In 23 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 22 days | ||
| General meeting for 2026 | 2026-05-29 09:00 | 2.72 (+2.26%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 3.44 (+4.24%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 3.44 (+4.24%) | ||
| Annual report for 2025 | 2026-03-04 | 3.96 (+3.66%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 16:30 | 3.96 (-2.46%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | 3.96 (-2.46%) |
Show
Entries
Sensus Healthcare Inc Frequently Asked Questions
What is Sensus Healthcare Inc(STU:5TX)'s stock price today?
The current price of STU:5TX is €2.68. The 52 week high of STU:5TX is €4.82 and 52 week low is €2.26.
When is next earnings date of Sensus Healthcare Inc(STU:5TX)?
The next earnings date of Sensus Healthcare Inc(STU:5TX) is 2026-08-07 Est..
Does Sensus Healthcare Inc(STU:5TX) pay dividends? If so, how much?
Sensus Healthcare Inc(STU:5TX) does not pay dividend.
Press Release
Articles on Sensus Healthcare Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers